Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$110.94 USD

110.94
7,458,602

+1.05 (0.96%)

Updated Aug 15, 2024 04:00 PM ET

After-Market: $110.95 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Tracey Ryniec headshot

5 Stocks with Spectacular Earnings Charts

These companies aren't just beating on earnings, their stocks are also on fire, hitting new 5-year highs.

Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand

The FDA approval for MitraClip G4 is expected to enhance Abbott's (ABT) cardiac treatment portfolio.

Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?

Abbott's (ABT) consistent rise on a strong Diabetes Care business performance is seen over the last few quarters.

ABT or BIO: Which Stock Has Better Potential Right Now?

Abbott (ABT) scores higher than Bio-Rad (BIO) in terms of valuation and one-year price performance.

Kevin Cook headshot

Bull of the Day: Penumbra (PEN)

This $6 billion innovator removes blood clots and the deadly shadow of stroke with catheter-based aspiration technologies

Abbott (ABT) Earnings Expected to Grow: Should You Buy?

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed the most recent trading day at $83.69, moving +0.88% from the previous trading session.

Abbvie Decides to Acquire Allergan

Abbvie Decides to Acquire Allergan

Mark Vickery headshot

AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20

AbbVie (ABBV) has agreed to purchase Botox maker Allergan (AGN) for roughly $63 billion in cash and stock.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed at $83.42 in the latest trading session, marking a +1.67% move from the prior day.

Abbott (ABT) Hits New 52-Week High on Solid Growth Drivers

Abbott (ABT) gains from expansion of product portfolio and several regulatory clearances.

Abbott (ABT) Moves to Buy: Rationale Behind the Upgrade

Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Abbott (ABT) closed at $81.24, marking a +0.62% move from the previous day.

The Zacks Analyst Blog Highlights: Mastercard, Disney, Abbott, Workday and Sun Life

The Zacks Analyst Blog Highlights: Mastercard, Disney, Abbott, Workday and Sun Life

Mark Vickery headshot

Top Research Reports for Mastercard, Disney & Abbott

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Disney (DIS) and Abbott (ABT).

Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?

Is (ABT) Outperforming Other Medical Stocks This Year?

Abbott (ABT) Gains But Lags Market: What You Should Know

Abbott (ABT) closed at $77.54 in the latest trading session, marking a +1.85% move from the prior day.

Abbott (ABT) Grows on EPD Amid Rhythm Management Challenges

We are optimistic about the steady growth trend in Abbott's (ABT) EPD and Medical Devices segments on an organic basis.

Abbott (ABT) Stock Moves -0.05%: What You Should Know

In the latest trading session, Abbott (ABT) closed at $75.67, marking a -0.05% move from the previous day.

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Abbott (ABT) closed at $75.64, marking a -0.81% move from the previous day.

Why Is Abbott (ABT) Up 3.6% Since Last Earnings Report?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Kevin Cook headshot

Bull of the Day: Penumbra (PEN)

This $4 billion innovator removes blood clots and the deadly shadow of stroke with catheter-based aspiration technologies

Abbott Rides on Strong CGM, Poor Rhythm Management Ails

Abbott (ABT) is attracting constant attention with developments in its flagship, sensor-based continuous glucose monitoring (CGM) system called FreeStyle Libre System.

Abbott (ABT) Upgraded to Buy: What Does It Mean for the Stock?

Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The Zacks Analyst Blog Highlights: Verizon, Abbott, Illinois Tool Works, Moody's and Baker Hughes

The Zacks Analyst Blog Highlights: Verizon, Abbott, Illinois Tool Works, Moody's and Baker Hughes